Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Menopur Pen vs Powder in Healthy Chinese Women
NCT04902131Phase 1Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2021
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of menotrophin in female infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Area under the concentration-time curve from time zero to the last quantifiable concentration for FSH at 216 hours and Maximum observed serum concentration for FSH at 216 hours. Started Nov 2021; status: completed.
02
Drugs
menotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04902131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04902131.